So far, only one SIRT3 transgenic mouse model has been reported, in which cardiac expression of the short-form SIRT3 protects mice againist angiotensin II-induced or isoproterenol-induced cardiac hypertrophy and fibrosis [21]. The gene discussed is SIRT3; the disease is cardiac hypertrophy.